ASTERION

Asterion is a privately held biopharmaceutical dedicated to provide innovative solutions for bacterial resistance in inflammatory skin disorders... Our phagendo technology promises to significantly improve therapeutic outcomes in inflammatory skin disorders where antibiotics fail. We have a deep and diverse pipeline at various stages of development for various skin disorders with a high level of unmet need... for decades We have been using antibiotics as if there was no biological cost. hence, the massive problem we now have to face.